Progression of matrixin and cardiokine expression patterns in an ovine model of heart failure and recovery

Int J Cardiol. 2015:186:77-89. doi: 10.1016/j.ijcard.2015.03.156. Epub 2015 Mar 17.

Abstract

Background: The molecular mechanisms underlying the geometrical changes of the left ventricle during the progression to heart failure and recovery are not well defined.

Objective: Here we investigate the involvement of matrixins and cardiokines in an ovine model of pressure-induced left ventricular failure (LVF).

Methods: Fifteen sheep underwent supracoronary aortic banding with an inflatable cuff. A controlled and progressive increase of LV pressure was monitored echocardiographically. Endomyocardial biopsies were collected throughout the development of LVF and subsequent recovery after pressure unloading.

Results: Thirteen sheep developed LVF with a subsequent recovery. Peak left ventricular hypertrophy (LVH) and dilatation (LVD) occurred at 31.5 ± 1.6 weeks and 102.7 ± 2.2 weeks post-banding respectively, with an increase in LV internal diameter in diastole (LVIDd 5.11 ± 0.12 compared to the control 3.37 ± 0.07 cm, p<0.001), with preserved LV ejection fraction (LVEF). Reduced LVEF became evident 116.5 ± 2.7 weeks post-banding. Clinical and echocardiographic improvements were observed following deflation of the aortic banding cuff. By 138.1 ± 3.1 weeks cardiac performance recovered with restoration of LVEF. Significant changes in the expression of matrix metalloproteinases (MMP)-1, -2, -3, vascular endothelial cell growth factor (VEGF), fibroblast growth factor (FGF)-2, interferon (INF)-α-2 and soluble CD40 ligand (sCD40L) were observed throughout the progression to failure and recovery.

Conclusions: We used an ovine model to study reversible LV remodelling without interruption and found significant changes in matrixin and cardiokine expression during LV progression to failure and recovery.

Keywords: Aortic banding; Cardiokines; Matrixins; Pressure overload.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / biosynthesis
  • Cytokines / genetics*
  • Disease Models, Animal
  • Disease Progression
  • Gene Expression Regulation*
  • Heart Failure / genetics*
  • Heart Failure / metabolism
  • Heart Failure / physiopathology
  • Immunoblotting
  • Matrix Metalloproteinases / biosynthesis
  • Matrix Metalloproteinases / genetics*
  • RNA / genetics*
  • Real-Time Polymerase Chain Reaction
  • Recovery of Function / physiology*
  • Sheep
  • Sheep, Domestic
  • Ventricular Remodeling*

Substances

  • Cytokines
  • RNA
  • Matrix Metalloproteinases